Volume 6, Issue 5: Trends in Inhaled Antibiotic Therapy

e-Cystic Fibrosis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Cystic Fibrosis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.

(Volume 6, Issue 5)

Target Audience

Nurses and health care professionals involved in the care of patients with Cystic Fibrosis.

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to: 

  • Describe the clinical use patterns of the available inhaled antibiotics for managing Pseudomonas aeruginosa in patients with cystic fibrosis.
  • Summarize the comparative safety and efficacy data between tobramycin nebulizer solution (TNS) and aztreonam for inhalation solution (AZLI).
  • Summarize the comparative safety and efficacy data between tobramycin nebulizer solution (TNS) and colistimethate dry powder for inhalation (CDPI).
Additional information
Contact email: 
Course summary
Available credit: 
  • 1.00 ANCC
  • 1.00 Attendance
Course opens: 
04/19/2016
Course expires: 
04/18/2018
Cost:
$0.00

Daniel Heintz, MD
Fellow, Pediatric Cystic Fibrosis Center 
Nationwide Children’s Hospital
Columbus, Ohio

 
Karen McCoy, MD
Director, Pediatric Cystic Fibrosis Center
Nationwide Children’s Hospital
Columbus, Ohio

Available Credit

  • 1.00 ANCC
  • 1.00 Attendance

Accreditation Period

Course opens: 
04/19/2016
Course expires: 
04/18/2018

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

Make sure your Adobe flash is updated by clicking HERE